<--- Back to Details
First PageDocument Content
Macular degeneration / Stem cells / Retinal pigment epithelium / ABCA4 / Choroidal neovascularization / Ranibizumab / Scanning laser ophthalmoscopy / Cell therapy / Drusen / Biology / Ophthalmology / Medicine
Date: 2014-11-28 01:03:55
Macular degeneration
Stem cells
Retinal pigment epithelium
ABCA4
Choroidal neovascularization
Ranibizumab
Scanning laser ophthalmoscopy
Cell therapy
Drusen
Biology
Ophthalmology
Medicine

MD Research News Issue 208 Tuesday 25 November, 2014 This free weekly bulletin lists the latest published research articles on macular degeneration (MD) and some other

Add to Reading List

Source URL: www.mdfoundation.com.au

Download Document from Source Website

File Size: 419,02 KB

Share Document on Facebook

Similar Documents

CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

DocID: 1pDeC - View Document

LABORATORY SCIENCES  Preclinical Evaluation of the Novel Small-Molecule Integrin ␣5␤1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization Grit Zahn, PhD; Dörte Vossmeyer, PhD; Roland Stragi

LABORATORY SCIENCES Preclinical Evaluation of the Novel Small-Molecule Integrin ␣5␤1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization Grit Zahn, PhD; Dörte Vossmeyer, PhD; Roland Stragi

DocID: 1lkvp - View Document

PRESTATIE- EN TARIEFBESCHIKKING ADD-ON RANIBIZUMAB Nummer  Datum inwerkingtreding

PRESTATIE- EN TARIEFBESCHIKKING ADD-ON RANIBIZUMAB Nummer Datum inwerkingtreding

DocID: 1cIqP - View Document

FOR IMMEDIATE RELEASE  Quinton Oswald Appointed Chief Executive Officer of Neurotech Pharmaceuticals Seasoned Executive Brings Wealth of Experience to Ophthalmic Biotechnology Pioneer, Including Leadership of SARcode Bio

FOR IMMEDIATE RELEASE Quinton Oswald Appointed Chief Executive Officer of Neurotech Pharmaceuticals Seasoned Executive Brings Wealth of Experience to Ophthalmic Biotechnology Pioneer, Including Leadership of SARcode Bio

DocID: 1a9Xb - View Document

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

DocID: 19zgB - View Document